Joint Variable Selection for Omic Biomarkers in Time-to-Event Data
Jakub BajzíkiD, Al DepopeiD, Yasaman ZolfimoseloiD, Alexander Sharipov, Alexandra LesayováiD, Holger KleiniD, Anne RichmondiD, Spyros I. VernardisiD, Arturas GrauslysiD, Sergej AndrejeviD, Aleksej ZelezniakiD, Markus RalseriD, Riccardo Emilio MarioniiD, Marco MondelliiD, Matthew R. RobinsoniD
Abstract
The incidence of the vast majority of neurodegenerative, cancer, and metabolic diseases generally increases exponentially with age. In large-scale biobanks, linking time-to-diagnosis information in electronic health records to multiple genomic (``multiomics'') measures has the potential to reveal the genes and biological pathways involved in the disease onset and progression. To date, association testing has commonly been conducted by testing one variable at a time using semiparametric Cox proportional hazards (CoxPH) models, which ignores correlation structure and increases the risk of false discoveries. To address these issues, we introduce a novel fully parametric Bayesian computational method, vampW, based on the Vector Approximate Message Passing framework applied to a Weibull model. vampW jointly models correlated features, while providing an interpretable hazard structure, producing a continuous survival curve, and incorporating prior knowledge. In an extensive simulation study, we demonstrate that joint modeling of omics data and time-to-event outcomes with vampW, substantially reduces false discoveries in comparison to marginal testing and other forms of joint CoxPH models. In 53,018 individuals from the UK Biobank, vampW identifies 219 protein associations with 24 disease outcomes, most of which are not among the top marginal discoveries. We further correct protein levels for exponential age effects, identifying 1,308 associations and highlighting the sensitivity of the analysis to age-correction methodology. Our findings replicate in independent cohorts using different measurement technologies, within data from Iceland and a novel Generation Scotland proteomics dataset. vampW also achieves significant improvement in the prediction of disease onset times: across 14 outcomes, it reduces the root mean squared error by over 30% and 26%, when compared to CoxPH variants and the deep learning approach DeepSurv, respectively, while maintaining predictive utility in minority populations. In summary, vampW offers accurate and interpretable variable selection and out-of-sample prediction within a single computational framework, making it a powerful tool for dissecting the genomic architecture of common complex disease onset.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Regularized Cox Hierarchical Model for Incorporating Annotation Information in Predictive Omic Studies
Dixin Shen, Juan Pablo Lewinger, Eric S. Kawaguchi·BioData MiningPeer-reviewed·Oct 24, 2024
- MMAD-Risk: Multivariate Mixed Survival Analysis for the Prediction of Age-Dependent Disease Risks from Plasma Proteomes
Amelie Maria Hilger, Johannes Söding·bioRxiv·Sep 17, 2026
- Integrative machine learning approaches for predicting disease risk using multi-omics data from the UK Biobank
Oscar Aguilar, Cheng Chang, … Manuel A. Rivas·bioRxiv·Apr 16, 2024
- Genomic architecture and prediction of censored time-to-event phenotypes with a Bayesian genome-wide analysis
Sven E. Ojavee, Athanasios Kousathanas, … Matthew R. Robinson·Nature CommunicationsPeer-reviewed·Apr 20, 2021
- OMICmAge: An integrative multi-omics approach to quantify biological age with electronic medical records
Qingwen Chen, Varun Bhamidipati Dwaraka, … Jessica Ann Lasky-Su·bioRxiv·Oct 16, 2023
- Improving population-scale disease prediction through multi-omics integration
Esther S. Ng, Ruth Nanjala, … Yang Luo·medRxiv·Nov 24, 2025